Youcare Pharmaceutical Group Co.,Ltd.(688658),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

688658 Youcare Pharmaceutical Group Co.,Ltd.

Closed 12-12 15:00:01

24.56

-2.28

-8.49%

High27.09	Low23.44	Vol18.75M
Open27.09	D1 Closing26.84	Amplitude13.60%
Mkt Cap11.05B	Tradable Cap11.05B	Total Shares450.00M
T/O459.00M	T/O Rate4.17%	Tradable Shares450.00M
P/B3.22	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688658","market":"SH","secType":"STK","nameCN":"Youcare Pharmaceutical Group Co.,Ltd.","latestPrice":24.56,"timestamp":1765522801000,"preClose":26.84,"halted":0,"volume":18748298,"delay":0,"changeRate":-0.0849,"floatShares":450000000,"shares":450000000,"eps":-0.52,"marketStatus":"Closed","change":-2.28,"latestTime":"12-12 15:00:01","open":27.09,"high":27.09,"low":23.44,"amount":459000000,"amplitude":0.136,"askPrice":24.56,"askSize":134,"bidPrice":24.48,"bidSize":9,"shortable":0,"etf":0,"ttmEps":-0.52,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":26.84,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":29.52,"lowLimit":24.16,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":450000000,"isCdr":false,"pbRate":3.22,"roa":"--","roe":"--","epsLYR":0.28,"committee":-0.616642,"marketValue":11052000000,"turnoverRate":0.0417,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-12-15.","afterMarket":{"amount":0,"volume":0,"close":24.56,"buyVolume":0,"sellVolume":0,"time":1765524839585,"indexStatus":"Closed 12-12 15:30:00","preClose":26.84},"floatMarketCap":11052000000},"requestUrl":"/m/hq/s/688658","defaultTab":"news","newsList":[{"id":"1192573539","title":"Youcare Pharmaceutical Group (688658.SH) Gains Approval for YKYY031 Injection in Late-Stage Solid Tumor Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1192573539","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192573539?lang=en_us&edition=fundamental","pubTime":"2025-12-12 17:30","pubTimestamp":1765531826,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical Group Co., Ltd. (688658.SH) announced that its wholly-owned subsidiaries, Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. and Hangzhou Tianlong Pharmaceutical Co.,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688658"],"gpt_icon":0},{"id":"1132274427","title":"Youcare Pharmaceutical's Song Gengshen Warns: GLP-1 Weight Loss Drugs May Cause Depression, Dubbed \"Emotion-Numbing Medication\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1132274427","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132274427?lang=en_us&edition=fundamental","pubTime":"2025-12-11 10:33","pubTimestamp":1765420388,"startTime":"0","endTime":"0","summary":"The \"2025 China Enterprise Competitiveness Annual Conference\" was held in Beijing from December 9 to 10. Song Gengshen, Director of the Drug Research Institute and Board Member of Youcare...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK4590","GLP","BK4144","688658"],"gpt_icon":0},{"id":"1134437666","title":"Youcare Pharmaceutical Group (688658.SH) Plans H-Share Listing on Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1134437666","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134437666?lang=en_us&edition=fundamental","pubTime":"2025-12-05 17:22","pubTimestamp":1764926542,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical Group Co., Ltd. (688658.SH) announced plans to issue H-shares and list on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX). The move aims to enhance the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2589898142","title":"Youcare Pharmaceutical Group  Says Co Plans to Seek Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2589898142","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589898142?lang=en_us&edition=fundamental","pubTime":"2025-12-05 17:21","pubTimestamp":1764926501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL4N3XB0PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2589898108","title":"BRIEF-Youcare Pharmaceutical Group Plans To Seek Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2589898108","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589898108?lang=en_us&edition=fundamental","pubTime":"2025-12-05 17:21","pubTimestamp":1764926501,"startTime":"0","endTime":"0","summary":"BRIEF-Youcare Pharmaceutical Group Plans To Seek Hong Kong ListingDec 5 (Reuters) - Youcare Pharmaceutical Group Co Ltd 688658.SS:SAYS CO PLANS TO SEEK HONG KONG LISTINGSource textFurther company coverage: 688658.SS (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nL4N3XB0PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2588094543","title":"Youcare Pharmaceutical Unit Gets Approval for Clinical Trial of Nebulized Inhalation Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2588094543","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588094543?lang=en_us&edition=fundamental","pubTime":"2025-12-03 12:27","pubTimestamp":1764736074,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical's  unit, Beijing Yuenkang Kechuang Pharmaceutical Technology, received two approvals from China's National Medical Products Administration for its clinical trials applications, according to a Wednesday filing on the Shanghai bourse.The regulator allowed the pharmaceutical company to trial the YKYY018 nebulized inhalation formulation for post-exposure prophylaxis after contact with patients infected with respiratory syncytial virus  or RSV infection.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"1103090478","title":"Youcare Pharmaceutical Group's Subsidiary Receives Clinical Trial Approval for YKYY018 Inhalation Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=1103090478","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103090478?lang=en_us&edition=fundamental","pubTime":"2025-12-02 16:20","pubTimestamp":1764663626,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical Group Co.,Ltd. (688658.SH) announced that its wholly-owned subsidiary, Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., has recently received two \"Drug Clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688658"],"gpt_icon":0},{"id":"1107586420","title":"Youcare Pharmaceutical's Subsidiary Receives FDA Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1107586420","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107586420?lang=en_us&edition=fundamental","pubTime":"2025-11-30 22:51","pubTimestamp":1764514263,"startTime":"0","endTime":"0","summary":"On November 28, Youcare Pharmaceutical Group Co., Ltd. (referred to as \"Youcare Pharmaceutical\") announced that its wholly-owned subsidiary, Beijing Youcare Kechuang Pharmaceutical Technology Co.,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2586205808","title":"Youcare Pharmaceutical Gets U.S. FDA Nod for YKYY018 Inhalation Aerosol's Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586205808","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586205808?lang=en_us&edition=fundamental","pubTime":"2025-11-28 13:54","pubTimestamp":1764309246,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical  received approval from the U.S. Food and Drug Administration for the clinical trial application for YKYY018 inhalation aerosol, according to a Friday disclosure on the Shanghai bourse.The drug will be tested as a prevention and treatment of respiratory syncytial virus infection.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"1161185543","title":"Youcare Pharmaceutical Group's (688658.SH) Subsidiary Receives FDA Approval for YKYY018 Inhalation Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1161185543","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161185543?lang=en_us&edition=fundamental","pubTime":"2025-11-27 16:10","pubTimestamp":1764231017,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical Group Co., Ltd. (688658.SH) announced that its wholly-owned subsidiary, Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., has received a Study May Proceed Letter...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2581680610","title":"Youcare Pharmaceutical Subsidiaries Get Clinical Trial Nod for Hepatitis B Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2581680610","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581680610?lang=en_us&edition=fundamental","pubTime":"2025-11-06 18:19","pubTimestamp":1762424357,"startTime":"0","endTime":"0","summary":"Chinese authorities granted Youcare Pharmaceutical  subsidiaries Beijing Yuekang Kechuang Pharmaceutical Technology and Hangzhou Tianlong Pharmaceutical a clinical trial approval for its chronic hepatitis B virus treatment, according to a Thursday filing with the Shanghai bourse.The drug inhibits the production of the hepatitis B virus genome and suppresses replication, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"1165737584","title":"Youcare Pharmaceutical Group (688658.SH) Subsidiary Receives Clinical Trial Approval for YKYY013 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1165737584","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165737584?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:18","pubTimestamp":1762330692,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical Group Co., Ltd. (688658.SH) announced that its subsidiaries, Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. (\"Youcare Kechuang\") and Hangzhou Tianlong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2569934267","title":"US FDA Approves Youcare Pharmaceutical Subsidiary's Clinical Trial for Hepatitis B Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2569934267","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569934267?lang=en_us&edition=fundamental","pubTime":"2025-09-23 16:58","pubTimestamp":1758617924,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration approved Youcare Pharmaceutical  subsidiary Beijing Yuekang Kechuang Pharmaceutical Technology's clinical trial for its YKYY013 injection, according to a Tuesday filing with the Shanghai bourse.The injection is indicated for chronic hepatitis B virus, the filing said.Shares closed 3% lower on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"1126418284","title":"Youcare Pharmaceutical Group (688658.SH) Subsidiary Receives FDA Clinical Trial Approval for YKYY013 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1126418284","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126418284?lang=en_us&edition=fundamental","pubTime":"2025-09-22 17:20","pubTimestamp":1758532837,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical Group Co.,Ltd. (688658.SH) announced that its subsidiary Beijing Youcare Innovation Medical Technology Co., Ltd. (referred to as \"Youcare Innovation\") recently received a Study...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688658","BK0239"],"gpt_icon":0},{"id":"1163149918","title":"2024 A-Share Independent Director Data Report: Cnooc Limited's Li Shuxian Receives Highest Compensation of 1.07 Million Yuan, Youcare Pharmaceutical's Chen Keji at 95 is the Oldest","url":"https://stock-news.laohu8.com/highlight/detail?id=1163149918","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163149918?lang=en_us&edition=fundamental","pubTime":"2025-08-26 18:31","pubTimestamp":1756204285,"startTime":"0","endTime":"0","summary":"The independent director system serves as a crucial component of listed companies' governance structure, playing an active role in promoting standardized corporate operations, protecting the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD","600938","BK0274","399300","159982","688658"],"gpt_icon":0},{"id":"2553279054","title":"Youcare Pharmaceutical's Unit Gets US FDA Nod to Trial Hypertension Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2553279054","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553279054?lang=en_us&edition=fundamental","pubTime":"2025-07-24 14:36","pubTimestamp":1753339001,"startTime":"0","endTime":"0","summary":"Youcare Pharmaceutical's  unit, Beijing Yuekang Kechuang Pharmaceutical Technology, has secured approval from the US Food and Drug Administration to conduct clinical trials on YKYY029 injection, according to a Shanghai bourse filing on Thursday.The pharmaceutical company will trial the drug as a hypertension treatment, the filing said.The company's shares fell over 2% during afternoon trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688658","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-12-24","address":"北京市大兴区北京经济技术开发区宏达中路6号","stockEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":0.1439},{"period":"3month","weight":-0.0144},{"period":"6month","weight":0.4262},{"period":"1year","weight":0.1922},{"period":"ytd","weight":0.7044}],"companyName":"悦康药业集团股份有限公司","boardCode":"AI0027","perCapita":"42095股","boardName":"医药制造业","registeredCapital":"45000万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　悦康药业集团股份有限公司的主营业务是原料药及制剂相关产品的生产和销售。公司的主要产品是银杏叶提取物注射液、天麻素注射液、注射用兰索拉唑、奥美拉唑肠溶胶囊、盐酸二甲双胍缓释片、注射用头孢呋辛钠、注射用头孢曲松钠。公司连续多年荣获工信部医药工业百强和中国医药研发产品线最佳工业企业的殊荣，入榜《2025年中国药品研发综合实力排行榜TOP100》并荣登《2025中国中药研发实力排行榜》第六名。2024年，公司“头孢菌素类抗生素原料药关键技术研究及产业化应用”项目，荣获河南省科学技术进步三等奖，彰显了公司在医药领域的卓越成就和创新实力。","serverTime":1765708978849,"listedPrice":24.36,"stockholders":"10690人(较上一季度减少8.39%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Youcare Pharmaceutical Group Co.,Ltd.(688658),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Youcare Pharmaceutical Group Co.,Ltd.(688658) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Youcare Pharmaceutical Group Co.,Ltd.,688658,Youcare Pharmaceutical Group Co.,Ltd.股票,Youcare Pharmaceutical Group Co.,Ltd.股票老虎,Youcare Pharmaceutical Group Co.,Ltd.股票老虎国际,Youcare Pharmaceutical Group Co.,Ltd.行情,Youcare Pharmaceutical Group Co.,Ltd.股票行情,Youcare Pharmaceutical Group Co.,Ltd.股价,Youcare Pharmaceutical Group Co.,Ltd.股市,Youcare Pharmaceutical Group Co.,Ltd.股票价格,Youcare Pharmaceutical Group Co.,Ltd.股票交易,Youcare Pharmaceutical Group Co.,Ltd.股票购买,Youcare Pharmaceutical Group Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Youcare Pharmaceutical Group Co.,Ltd.(688658),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Youcare Pharmaceutical Group Co.,Ltd.(688658) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction